Monopar Therapeutics (MNPR) Insider Trading & Ownership $32.06 +0.22 (+0.69%) Closing price 04:00 PM EasternExtended Trading$32.06 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics (NASDAQ:MNPR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25.19KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$2.87M Get MNPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MNPR Insider Buying and Selling by Quarter Monopar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/14/2025Chandler RobinsonCEOSell16,800$40.00$672,000.00 7/14/2025Christopher M StarrDirectorSell16,800$40.00$672,000.00 7/14/2025Kim R TsuchimotoDirectorSell8,904$40.00$356,160.00 4/2/2025Tactic Pharma LlcMajor ShareholderSell33,334$35.00$1,166,690.00 10/28/2024Karthik RadhakrishnanCFOBuy1,550$16.25$25,187.50 (Data available from 1/1/2013 forward) MNPR Insider Trading Activity - Frequently Asked Questions Who is on Monopar Therapeutics' Insider Roster? The list of insiders at Monopar Therapeutics includes Andrew Cittadine, Chandler Robinson, Christopher M Starr, Karthik Radhakrishnan, Kim R Tsuchimoto, and Tactic Pharma Llc. Learn more on insiders at MNPR. What percentage of Monopar Therapeutics stock is owned by insiders? 20.50% of Monopar Therapeutics stock is owned by insiders. Learn more on MNPR's insider holdings. Which Monopar Therapeutics insiders have been buying company stock? The following insiders have purchased MNPR shares in the last 24 months: Andrew Cittadine ($61,373.70), and Karthik Radhakrishnan ($25,187.50). How much insider buying is happening at Monopar Therapeutics? Insiders have purchased a total of 17,651 MNPR shares in the last 24 months for a total of $86,561.20 bought. Which Monopar Therapeutics insiders have been selling company stock? The following insiders have sold MNPR shares in the last 24 months: Chandler Robinson ($672,000.00), Christopher M Starr ($672,000.00), Kim R Tsuchimoto ($356,160.00), and Tactic Pharma Llc ($1,166,690.00). How much insider selling is happening at Monopar Therapeutics? Insiders have sold a total of 75,838 Monopar Therapeutics shares in the last 24 months for a total of $2,866,850.00 sold. Monopar Therapeutics Key ExecutivesDr. Chandler D. Robinson M.B.A. (Age 40)M.D., M.Sc., MBA, MSc, Co-Founder, CEO, President & Director Compensation: $710.5kMs. Kim R. Tsuchimoto CPA (Age 61)CFO, Secretary, Treasurer & Director Compensation: $354k1 recent tradesMr. Andrew J. Cittadine M.B.A. (Age 51)Chief Operating Officer Compensation: $416.7kDr. Patrice P. Rioux M.D. (Age 73)Ph.D., Acting Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Precigen Insider Selling Akebia Therapeutics Insider Selling Anavex Life Sciences Insider Selling Nurix Therapeutics Insider Selling Niagen Bioscience Insider Selling ArriVent BioPharma Insider Selling Sana Biotechnology Insider Selling Gyre Therapeutics Insider Selling Ginkgo Bioworks Insider Selling atai Life Sciences Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:MNPR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access